Statistics

Total Visits

Views
cost-saving approach to triple therapy for hepatitis C using the OPTIM prognostic tool to predict virologic response to 4 weeks of peginterferon and ribavirin in genotype 1 patients74

Select a period of time:

Number of views in the range

Views
cost-saving approach to triple therapy for hepatitis C using the OPTIM prognostic tool to predict virologic response to 4 weeks of peginterferon and ribavirin in genotype 1 patients15

Views

Views
December 20252
January 20260
February 20261
March 20263
April 20262
May 20265
June 20262
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States4
Netherlands2
United Kingdom2
Argentina1
China1
Colombia1
Finland1
France1
Peru1
Venezuela1
 

Top cities views

Views
Groningen2
Ashburn1
Catamarca1
Helsinki1
Lima1
Maracaibo1
Pasto1
Philadelphia1